166 related articles for article (PubMed ID: 22714808)
1. Efficacy of the dietary histone deacetylase inhibitor butyrate alone or in combination with vitamin A against proliferation of MCF-7 human breast cancer cells.
Andrade FO; Nagamine MK; Conti AD; Chaible LM; Fontelles CC; Jordão Junior AA; Vannucchi H; Dagli ML; Bassoli BK; Moreno FS; Ong TP
Braz J Med Biol Res; 2012 Sep; 45(9):841-50. PubMed ID: 22714808
[TBL] [Abstract][Full Text] [Related]
2. Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast cancer and leukemia cell lines.
Foglietta F; Serpe L; Canaparo R; Vivenza N; Riccio G; Imbalzano E; Gasco P; Zara GP
J Pharm Pharm Sci; 2014; 17(2):231-47. PubMed ID: 24934552
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells.
Davis T; Kennedy C; Chiew YE; Clarke CL; deFazio A
Clin Cancer Res; 2000 Nov; 6(11):4334-42. PubMed ID: 11106251
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells.
Zhou Q; Dalgard CL; Wynder C; Doughty ML
BMC Neurosci; 2011 May; 12():50. PubMed ID: 21615950
[TBL] [Abstract][Full Text] [Related]
5. Anti-estrogenic actions of histone deacetylase inhibitors in MCF-7 breast cancer cells.
De los Santos M; Martínez-Iglesias O; Aranda A
Endocr Relat Cancer; 2007 Dec; 14(4):1021-8. PubMed ID: 18045953
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitor sodium butyrate suppresses DNA double strand break repair induced by etoposide more effectively in MCF-7 cells than in HEK293 cells.
Li L; Sun Y; Liu J; Wu X; Chen L; Ma L; Wu P
BMC Biochem; 2015 Jan; 16():2. PubMed ID: 25592494
[TBL] [Abstract][Full Text] [Related]
8. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
9. Chemopreventive effects of the dietary histone deacetylase inhibitor tributyrin alone or in combination with vitamin A during the promotion phase of rat hepatocarcinogenesis.
de Conti A; Kuroiwa-Trzmielina J; Horst MA; Bassoli BK; Chagas CE; Purgatto E; Cavalher FP; Camargo AA; Jordão AA; Vannucchi H; Scolastici C; Ong TP; Moreno FS
J Nutr Biochem; 2012 Aug; 23(8):860-6. PubMed ID: 21940155
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors promote the expression of ATP2A3 gene in breast cancer cell lines.
Contreras-Leal E; Hernández-Oliveras A; Flores-Peredo L; Zarain-Herzberg Á; Santiago-García J
Mol Carcinog; 2016 Oct; 55(10):1477-85. PubMed ID: 26331238
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of sodium butyrate, a histone deacetylase inhibitor, on increase of neurogenesis induced by pyridoxine and increase of neural proliferation in the mouse dentate gyrus.
Yoo DY; Kim W; Nam SM; Kim DW; Chung JY; Choi SY; Yoon YS; Won MH; Hwang IK
Neurochem Res; 2011 Oct; 36(10):1850-7. PubMed ID: 21597935
[TBL] [Abstract][Full Text] [Related]
12. The enhanced apoptosis and antiproliferative response to combined treatment with valproate and nicotinamide in MCF-7 breast cancer cells.
Jafary H; Ahmadian S; Soleimani M
Tumour Biol; 2014 Mar; 35(3):2701-10. PubMed ID: 24213853
[TBL] [Abstract][Full Text] [Related]
13. Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells.
Mathew OP; Ranganna K; Yatsu FM
Biomed Pharmacother; 2010 Dec; 64(10):733-40. PubMed ID: 20970954
[TBL] [Abstract][Full Text] [Related]
14. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression.
Siavoshian S; Segain JP; Kornprobst M; Bonnet C; Cherbut C; Galmiche JP; Blottière HM
Gut; 2000 Apr; 46(4):507-14. PubMed ID: 10716680
[TBL] [Abstract][Full Text] [Related]
15. [Effects of sodium butyrate on proliferation of human gastric cancer cells and expression of p16 gene].
Shen WJ; Dai DQ; Teng Y; Liu J
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1192-6. PubMed ID: 18844115
[TBL] [Abstract][Full Text] [Related]
16. 3,3'-diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivin.
Bhatnagar N; Li X; Chen Y; Zhou X; Garrett SH; Guo B
Cancer Prev Res (Phila); 2009 Jun; 2(6):581-9. PubMed ID: 19470789
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.
Li Y; Meeran SM; Patel SN; Chen H; Hardy TM; Tollefsbol TO
Mol Cancer; 2013 Feb; 12():9. PubMed ID: 23379261
[TBL] [Abstract][Full Text] [Related]
18. The combination effect of sodium butyrate and 5-Aza-2'-deoxycytidine on radiosensitivity in RKO colorectal cancer and MCF-7 breast cancer cell lines.
Cho HJ; Kim SY; Kim KH; Kang WK; Kim JI; Oh ST; Kim JS; An CH
World J Surg Oncol; 2009 May; 7():49. PubMed ID: 19460134
[TBL] [Abstract][Full Text] [Related]
19. Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex.
Walker GE; Wilson EM; Powell D; Oh Y
Endocrinology; 2001 Sep; 142(9):3817-27. PubMed ID: 11517158
[TBL] [Abstract][Full Text] [Related]
20. [In vitro study about the inhibitory effect of CDAII in combination with sodium butyrate on breast cancer cells].
Zhu Y; Zhao YL; Bu DF; Shi YJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 39(5):476-80. PubMed ID: 17940563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
